-
1.
公开(公告)号:US11065217B2
公开(公告)日:2021-07-20
申请号:US15903514
申请日:2018-02-23
Inventor: Ira C. Spector , Mark A. Feitelson , Alla Arzumanyan
Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
-
公开(公告)号:US20180008565A1
公开(公告)日:2018-01-11
申请号:US15545371
申请日:2016-01-21
Inventor: Mark A. Feitelson , Helena M.G.P.V. Reis
CPC classification number: A61K31/19 , A61K9/0053 , A61K35/744 , A61K35/747 , A61P35/00
Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
-
公开(公告)号:US20240342122A1
公开(公告)日:2024-10-17
申请号:US18609070
申请日:2024-03-19
Inventor: Mark A. Feitelson
IPC: A61K31/19 , A61K9/00 , A61K35/744 , A61K35/747 , A61P35/00
CPC classification number: A61K31/19 , A61K9/0053 , A61K35/744 , A61K35/747 , A61P35/00
Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
-
4.
公开(公告)号:US11759442B2
公开(公告)日:2023-09-19
申请号:US17350110
申请日:2021-06-17
Inventor: Ira C. Spector , Mark A. Feitelson , Alla Arzumanyan
CPC classification number: A61K31/19 , A61K9/0014 , A61K9/0048 , A61K9/4891 , A61K45/06 , A61P17/00 , A61P27/02 , A61P35/00 , A61P37/08 , A61K2300/00 , A61K31/19 , A61K2300/00
Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
-
5.
公开(公告)号:US20250099410A1
公开(公告)日:2025-03-27
申请号:US18975545
申请日:2024-12-10
Inventor: Alla ARZUMANYAN , Ira C. Spector , Mark A. Feitelson
Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
-
公开(公告)号:US11963938B2
公开(公告)日:2024-04-23
申请号:US17379305
申请日:2021-07-19
Inventor: Mark A. Feitelson
IPC: A61K31/19 , A61K9/00 , A61K35/744 , A61K35/747 , A61P35/00
CPC classification number: A61K31/19 , A61K9/0053 , A61K35/744 , A61K35/747 , A61P35/00
Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
-
公开(公告)号:US20190160031A1
公开(公告)日:2019-05-30
申请号:US16261836
申请日:2019-01-30
Inventor: Mark A. Feitelson
IPC: A61K31/19 , A61P35/00 , A61K9/00 , A61K35/744 , A61K35/747
Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
-
8.
公开(公告)号:US20180214399A1
公开(公告)日:2018-08-02
申请号:US15903514
申请日:2018-02-23
Inventor: Ira C. Spector , Mark A. Feitelson , Alla Arzumanyan
CPC classification number: A61K31/19 , A61K9/0014 , A61K9/0048 , A61K9/4891 , A61K45/06 , A61K2300/00 , A61P17/00 , A61P27/02 , A61P35/00 , A61P37/08
Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
-
9.
公开(公告)号:US20220142978A1
公开(公告)日:2022-05-12
申请号:US17584125
申请日:2022-01-25
Inventor: Alla ARZUMANYAN , Ira C. Spector , Mark A. Feitelson
IPC: A61K31/404 , A61K31/19 , A61K31/593 , A61P37/06 , A61P17/06
Abstract: The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.
-
公开(公告)号:US20220008369A1
公开(公告)日:2022-01-13
申请号:US17379305
申请日:2021-07-19
Inventor: Mark A. Feitelson
IPC: A61K31/19 , A61P35/00 , A61K9/00 , A61K35/744 , A61K35/747
Abstract: The invention relates to compositions for preventing or delaying the onset of hepatocellular cancer. The compositions of the invention may comprise short chain fatty acids. The compositions of the invention may also comprise probiotic bacteria. The compositions of the invention include compositions for preventing or delaying the onset of hepatocellular cancer by treating or preventing liver inflammation, liver disease, and precancerous lesions.
-
-
-
-
-
-
-
-
-